1FX Stock Overview
Invests in the medicinal and therapeutic cannabis market in the United Kingdom and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Ananda Developments Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.0025 |
| 52 Week High | UK£0.008 |
| 52 Week Low | UK£0.0015 |
| Beta | 0.90 |
| 11 Month Change | 25.00% |
| 3 Month Change | -16.67% |
| 1 Year Change | 25.00% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -64.29% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1FX | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 0% | -5.0% | -1.3% |
| 1Y | 25.0% | -22.0% | 7.4% |
Return vs Industry: 1FX exceeded the German Pharmaceuticals industry which returned -21.6% over the past year.
Return vs Market: 1FX exceeded the German Market which returned 7.1% over the past year.
Price Volatility
| 1FX volatility | |
|---|---|
| 1FX Average Weekly Movement | 66.9% |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 1FX's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 1FX's weekly volatility has increased from 38% to 67% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | 12 | Melissa Sturgess | anandadevelopments.com |
Ananda Developments Plc, together with its subsidiaries, invests in the medicinal and therapeutic cannabis market in the United Kingdom and internationally. The company provides cannabinoid-based medicines for the treatment of chronic inflammatory pain conditions. It also grows melon and root tubers; develops and distributes health products; wholesales pharmaceutical goods; manufactures and sells organic basic and essential oils; and is involved in crop production activities.
Ananda Developments Plc Fundamentals Summary
| 1FX fundamental statistics | |
|---|---|
| Market cap | €16.31m |
| Earnings (TTM) | -€7.66m |
| Revenue (TTM) | €918.04 |
Over9,999x
P/S Ratio-2.1x
P/E RatioIs 1FX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1FX income statement (TTM) | |
|---|---|
| Revenue | UK£764.00 |
| Cost of Revenue | UK£0 |
| Gross Profit | UK£764.00 |
| Other Expenses | UK£6.37m |
| Earnings | -UK£6.37m |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0018 |
| Gross Margin | 100.00% |
| Net Profit Margin | -834,311.65% |
| Debt/Equity Ratio | -79.6% |
How did 1FX perform over the long term?
See historical performance and comparison